Table of Contents
Collaborations with China
COVID-19 Studies
Collaborations with China
COVID-19 Studies
The
Reagan-Udall Foundation for the FDA
listed a clinical trial called “A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector)” run with the
People's Liberation Army
of China.
1)
https://www.science.org/doi/10.1126/scitranslmed.aay7162
1)
A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) | Expanded Access Navigator.
Reagan-Udall Foundation for the FDA. Retrieved December 19, 2021, from
https://navigator.reaganudall.org/clinical-trial/phase-ii-clinical-trial-evaluate-recombinant-vaccine-covid-19-adenovirus-vector